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ABSTRACT
Banked, unrelated, partially HLA-matched, umbilical cord blood is an alternative stem cell source for patients
in need of transplantation therapy who lack traditionally matched donors. A presumed advantage of cord blood
is the ability to increase recruitment of donors of minority ethnic backgrounds. The American Red Cross Cord
Blood Program was established in 1999 with 6 banks and 10 collection sites throughout the country. Cord
blood donors self-report racial designations on questionnaires, and donor race was collected from each site.
Postprocessing nucleated cell counts and CD34 counts were obtained on the cord blood units, and results
from each racial group (white, black, Asian, Hispanic, and Native American) were compared in the natural
logarithmic scale by using analysis of variance. A total of 18878 donors consented: 64% white, 16% black, 12%
Hispanic, 4% Asian, 1% Native American, and 3% other. The Detroit area consented the highest percentage
of black donors (87%), San Diego consented the highest percentage of Hispanic donors (59%), and Oakland
consented the highest percentage of Asian donors (15%). Seven thousand eight hundred sixty-six cord blood
units have been banked for transplantation. The mean preprocessing nucleated cell count was 1220  106
(range, 327-7300 106). There was no difference among racial groups when controlled for site (P .395). The
mean CD34 count was 3.28  106. Blacks had a significantly lower CD34 count than the other racial/ethnic
groups in the Midwest, Northwest, and North Carolina collection sites. A racially diverse cord blood bank can
be achieved. Nucleated cell counts were similar among the different racial/ethnic groups. CD34 counts were
lower for blacks in some collection sites.
© 2004 American Society for Blood and Marrow Transplantation
KEY WORDS
● ●Cord blood Minority Donor recruitment
i
N
R
(
n
N
c
sNTRODUCTION
Myeloablative chemotherapy with or without ra-
iotherapy followed by allogeneic bone marrow or
tem cell transplantation has been shown to be an
ffective treatment for several cancers and genetic
isorders [1-3]. Unfortunately, the availability of
ransplantation is limited by the need for a compatible
onor source, and only 30% of patients have a suitably
atched sibling donor [4]. Several international reg-
B&MTstries of bone marrow donors, including the Anthony
olan Registry, the Caitlin Raymond International
egistry, and the National Marrow Donor Program
NMDP), were established to provide a stem cell do-
or source for patients without family donors [5]. The
MDP has 4,794,523 donors, of whom 1,259,186 are
lassiﬁed as nonwhite or minority [6].
Umbilical cord blood has been shown to contain
ufﬁcient progenitor cells to provide durable engraft-269
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2ent [7]. The ﬁrst related cord blood transplantation
as performed in France in 1988 in a patient with
anconi’s anemia [8]. The ﬁrst unrelated cord blood
ransplant was performed at Duke University in 1993
9]. Results in children who have undergone trans-
lantation with unrelated cord blood units show a
0% to 80% disease-free survival, depending on dis-
ase and age [10-13]. Umbilical cord blood transplan-
ation has been extended to adult patients, with dis-
ase-free survival rates ranging from 25% to 53%
14-16]. The cell dose infused is an important prog-
ostic factor in many of these studies; patients who
eceive a higher nucleated cell count per kilogram or
ore CD34 cells per kilogram experience improved
urvival [11,12,15].
To accommodate the clinical need, banks of cryo-
reserved umbilical cord blood cells have been estab-
ished worldwide [10,17-21]. A reported goal of many
ord blood banks is to provide a racially and ethnically
iverse donor pool to ensure equitable access to trans-
lant donors. However, early efforts in cord blood
anking showed that there was no improvement in the
ecruitment of minority cord blood donors over mi-
ority unrelated bone marrow donors in 4 of the 5
eographic areas studied [22].
In this study, we examined the racial/ethnic com-
osition of cord blood donors in the American Red
ross (ARC) Cord Blood Program and compared the
ucleated cell counts and CD34 cells achieved in the
ifferent racial/ethnic groups.
ATERIALS AND METHODS
ord Blood Donors
Cord blood donors were consented and enrolled
ccording to the procedures of the ARC Cord Blood
rogram [23]. The ARC Cord Blood Program, estab-
ished in 1999, is a national network of cord blood
anks. Donors were recruited from January 1999 to
eptember 2002. Maternal donors were recruited in
0 different collection locations: Florence, AL; Oak-
and and San Diego, CA; Silver Spring, MD; Worces-
er, MA; Detroit, MI; St. Paul, MN; Great Falls, MT;
urham, NC; and Portland, OR. All donors signed a
onsent form approved by the institutional review
oard of their participating hospital. Mothers self-
eported racial/ethnic background on a medical his-
ory and donor questionnaire. All areas used a similar
aternal questionnaire. Data used for this study are
he maternal race/ethnicity answers.
aboratory Data
Cord blood units that met standard processing
riteria were cryopreserved and frozen, according to
he techniques of Rubinstein et al. [24]. Cord blood
ells were processed in 6 processing laboratories of the c
70RC Cord Blood Program (San Diego, CA; Worces-
er, MA; Detroit, MI; St. Paul, MN; Durham, NC;
nd Portland, OR). Cell counts were performed with
tandard Coulter counters. Nucleated red blood cells
ere counted as part of the nucleated cells, and a
omment was made to the prospective transplant team
hen the nucleated red blood cell count was 20%.
n the Detroit program, the white blood cell count
as corrected for the nucleated red blood cells. Dif-
erentials were performed manually by using a Wright
tained smear [23]. Cell viability was assessed by
rypan blue dye viability or acridine orange and/or
ropidium iodide staining; cord blood units with
80% viability were excluded from the search.
D34 cells were analyzed by using one of the Inter-
ational Society for Hematotherapy and Graft Engi-
eering methods [25,26]. All the laboratories used the
tandard International Society of Hematotherapy and
raft Engineering dual-platform method, except for
uke, which used the ProCOUNT reagent kit (Bec-
on Dickinson, Franklin Lakes, NJ) and software [26].
he minimum standards for processing were 40 mL
ntil July 2001. After July 2001, minimum standards
o begin processing were changed to 80  108 nucle-
ted cells.
tatistical Analysis
The study population consisted of mothers who
onsented to donate cord blood. Frequency distribu-
ions provided the breakdown of these donors by eth-
icity and site. The numbers of cord blood units that
ere collected, banked, or discarded were also
ounted for the different racial groups and collection
enters. Reasons for cord blood units not being
anked included low volume, low total nucleated cell
ount, positive maternal infectious disease markers,
edical history exclusion, or processing laboratory
ssues. For purposes of statistical analyses, Native
mericans were combined with the racial classiﬁca-
ion of “other.” The 2 test was used to compare the
umber of donors and units banked between ethnic
roups. These tests were performed with all cord units
nd also separately for each collection site.
Preprocessing nucleated cell counts, postprocess-
ng nucleated cell counts, and CD34 counts had dis-
ributions that were distinctly skewed to the right.
herefore, these cell counts were analyzed in the
atural logarithmic scale. The mean values presented
n Results, including the tables and ﬁgure, are geo-
etric means. The 2-way analysis of variance
ANOVA) was used to evaluate the effects of site and
thnicity on the cell counts. If there was a signiﬁcant
nteraction between race and site, then each collection
ite was analyzed separately with a 1-way ANOVA of
thnicity on the number of cells. A P value .05 was
onsidered statistically signiﬁcant.
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Racial Diversity of Cord Blood Banks
BESULTS
acial/Ethnic Information on Consenting Mothers
A total of 18878 mothers consented to participate
n this study. The racial/ethnic background of these
onors is illustrated in Table 1. Sixty-four percent of
hese mothers were white, 16% were black, 12% were
ispanic, 4% were Asian, and 1% were Native Amer-
can. Three percent of mothers classiﬁed themselves
s other. The race/ethnicity was unknown for 96
0.5%) of those who consented. These mothers who
ad a missing race were excluded from further analy-
es.
acial/Ethnic Information by Collection Site
Table 2 demonstrates the racial/ethnic breakdown
f donors by collection site. The small number of
labama cords, which were processed in Massachu-
etts, were included with the Massachusetts cords.
he Midwest sites included St. Paul, MN, and De-
roit, MI. The Northwest sites included Great Falls,
T, and Portland, OR, and the California site cov-
red both Oakland and San Diego. The Capital area
efers to the Washington, DC, area. The highest per-
entage of black donors was recruited in Detroit (87%
f donors in this location). San Diego had the highest
ercentage of Hispanic donors (59%). Fifteen percent
f the donors in Oakland were Asian. The highest
able 1. Race/Ethnicity of Consented Mothers
Race/Ethnicity n (%)
hite 12,089 (64.0)
lack 3029 (16.1)
sian/Pacific Islander 837 (4.4)
ispanic 2192 (11.6)
ative American 128 (0.7)
ther 507 (2.2)
nknown 96 (0.5)
able 2. Ethnic Breakdown of Cord Blood Units Collected from Consen
Site White Black
assachusetts 2308 (89.4%) 41 (1.6%) 52
alifornia
Oakland 332 (34.6%) 252 (26.3%) 144
San Diego ARC 626 (33.0%) 21 (1.1%) 64
idwest
St. Paul 2336 (74.7%) 445 (14.2%) 180
Detroit 94 (9.6%) 849 (87.0%) 6
orthwest
Portland 2683 (78.5%) 232 (6.8%) 160
Great Falls 978 (91.2%) 10 (0.9%) 8
Capital area 985 (53.0%) 490 (26.4%) 127
Duke ARC 1747 (60.5%) 689 (23.8%) 96Table excludes the cords with missing ethnicity.
B&MTercentage of Native American donors (3%) was re-
ruited from Montana.
acial/Ethnic Information on Mothers of Cord
lood Units Banked for Transplantation
There were 15685 (83.5%) mothers who con-
ented to participate in the study and had cord blood
nits collected; 50% of the collected units (or 42% of
he number of consenting mothers) were banked for
ransplantation. Seven thousand eight hundred sixty-
ix cord blood units were banked for transplantation.
he ethnic/racial composition of the mothers whose
nits were banked for transplantation was as follows:
9% white, 12% black, 4% Asian, 12% Hispanic, and
% Native American. The percentage of consenting
hite donors whose units were banked was 45%, com-
ared with 32% for black donors and 36% for Asian
onors (P  .001). Figure 1 shows this relatively
reater loss of black and Asian donors from consent-
ng mothers to banked units.
The reasons why the cord blood unit could not be
anked included low volume (40 mL of cord blood;
2.1%), low cell count (after July, 2001, 80  108
ucleated cells; 26.5%), processing laboratory issues
5.2%), medical history exclusion (3.9%), positive in-
ectious disease marker (3.8%), and other (18.5%).
he most common reason for discard in the category
f positive infectious disease markers was a positive
epatitis serology. Table 3 demonstrates these discard
easons stratiﬁed by race/ethnicity. The biggest dif-
erence occurred in the category of positive infectious
isease markers; Asian donors had the highest per-
entage (15.7%) compared with the other racial/eth-
ic groups (P  .001), which reﬂects the known
igher hepatitis carrier rate in this population. The
olume of the discarded units ranged from a median of
1 mL in whites to 58 mL in Asians.
In addition, there seemed to be site-speciﬁc dif-
erences (Table 4). For instance, in California, the
hers by Site*
Ethnicity
Hispanic Native American/Other Total
) 83 (3.2%) 98 (3.8%) 2582
) 158 (16.5%) 73 (7.6%) 959
) 1126 (59.3%) 63 (3.3%) 1900
) 107 (3.4%) 58 (1.9%) 3126
) 21 (2.2%) 6 (0.6%) 976
) 138 (4.0%) 206 (6.0%) 3419
) 18 (1.7%) 58 (5.4%) 1072
) 212 (11.4%) 44 (2.4%) 1858
) 329 (11.4%) 29 (1.0%) 2890ted Mot
Asian
(2.0%
(15.0%
(3.4%
(5.8%
(0.6%
(4.7%
(0.8%
(6.8%
(3.3%271
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2idwest, the Capital area, the Northwest, and North
arolina, there was a signiﬁcant difference in the
ercentage of banked units among the different racial/
thnic groups. The P values here (2 test) represent
he equality of percentages across ethnic groups. Only
n Massachusetts, which had the highest percentage of
hite donors, was there no difference in the percentage
f banked units among the different racial/ethnic groups.
ucleated Cell Counts and CD34 Counts
The nucleated cell counts for the entire group
eparated by racial/ethnic categories are displayed in
able 5. For the entire cohort, the mean preprocess-
ng nucleated cell count was 1220  106 (range, 327-
300  106). The mean counts ranged from 1159 for
lacks to 1242 for whites. The 2-way ANOVA showed
o signiﬁcant effect of ethnicity (P  .389); however,
here was a difference among collection sites (P 
013) and a signiﬁcant interaction between sites and
igure 1. The percentage of consented mothers whose cord units
ere banked shown by race/ethnicity.
able 3. Reason for Discard of Cord Blood Units by Ethnicity
Variable White Bla
ow volume (<40 mL) 2090 (45.1%) 553 (3
ositive infectious disease marker 117 (2.5%) 73 (5
rocessing laboratory issues 280 (6.1%) 35 (2
edical history exclusion 158 (3.4%) 71 (4
ow cell count (<80  108 NC) 1138 (24.6%) 448 (3
ther 848 (18.3%) 282 (1C indicates nucleated cells.
72acial/ethnic groups (P .043). This indicates that, on
verage, the preprocessing total nucleated cell count
as similar among races, although this relationship
mong races varied greatly from site to site. For ex-
mple, Asians had the highest average preprocessing
otal nucleated cell counts in California and the lowest
n Washington, DC. Hispanic donors had the lowest
ell counts in California but the highest in the Mid-
est and North Carolina. Evaluating the individual
ites separately revealed that only in California and
orth Carolina were the preprocessing total nucle-
ted cell counts signiﬁcantly different among the ra-
ial/ethnic groups. Because of the large sample size,
mall differences among groups achieved statistical
igniﬁcance. The percentage difference between the
ighest and lowest mean cell counts among racial/
thnic categories was only 7.2%.
The statistical ﬁndings for volume and postpro-
essing nucleated cell counts were very similar to
hose presented previously for the preprocessing nu-
leated cells. The mean postprocessing nucleated cell
ount was 946 (range, 180-4550) and showed similar
ite-speciﬁc trends.
The CD34 counts stratiﬁed by racial/ethnic clas-
iﬁcation are outlined in Table 5. The mean CD34
ount for the entire cohort was 3.28  106, with a
ange of 0.09 to 44.51 106. The ethnicity, collection
ite, and interaction effects were signiﬁcant (P  .05).
nce again, racial/ethnic groups were compared in a
eparate analysis for each site. Signiﬁcant differences
n CD34 cell counts were found among races for the
idwest, Northwest, and North Carolina. At all 3 of
hese collection sites, blacks had the lowest average
alue. Unlike the preprocessing nucleated cell counts,
he CD34 counts had a pronounced difference be-
ween the minimum and the maximum mean for the
thnic groups. The relative percentage change was
9.7%. This large effect was primarily due to the low
verage CD34 counts in blacks.
We also studied the postprocessing nucleated cell
ount, as outlined in Table 5. Hispanics had the high-
st mean postprocessing nucleated cell count/volume
11.9  106/mL), and blacks had the lowest (11.0 
06/mL). The percentage difference between these 2
Ethnicity
Asian Hispanic Native American/Other
127 (33.8%) 315 (37.5%) 98 (39.8%)
59 (15.7%) 31 (3.7%) 10 (4.1%)
12 (3.2%) 49 (5.8%) 14 (5.7%)
16 (4.3%) 46 (5.5%) 1 (0.4%)
83 (22.1%) 265 (31.5%) 68 (27.8%)
79 (21.0%) 135 (16.1%) 55 (22.2%)ck
7.8%)
.0%)
.4%)
.9%)
0.6%)
9.3%)
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Broups was only 8.0%, similar to the preprocessing
ucleated cell count. The overall mean for all the
thnic/racial groups was 11.6  106/mL (range, 3.0-
9.4  106/mL). The main effects for ethnicity and
he collection sites were statistically signiﬁcant (P 
019 and P  .001, respectively). When each site was
nalyzed individually, only North Carolina was signif-
cantly different among racial/ethnic groups. This dif-
erence was due to the lower mean value for the blacks
ompared with the whites.
The standards for processing cord blood units
hanged in July 2001 to meet a minimum standard for
rocessing of 80  108 nucleated cells at all sites.
D34 cells were analyzed by ethnicity before and
fter July 2001. Most black donors were enrolled after
his date. After July 2001, there was a greater differ-
nce in CD34 cells among the different ethnic
roups. The CD34 cells ranged from 2.64  106 in
lacks to 3.35  106 in whites to 3.86  106 in Native
mericans and other ethnicities. These results, dis-
layed in Table 6, were statistically signiﬁcant.
ISCUSSION
Cord blood remains a viable stem cell source,
specially for those patients without a matched family
able 4. Percentage of Cord Blood Units Banked by Ethnicity
Site White (%) Black (%) Asian (%)
assachusetts 39.3 26.8 40.4
alifornia 40.9 19.8 34.1
idwest 44.8 29.0 30.7
orthwest 44.7 33.1 41.1
apital area 29.1 17.1 19.7
orth Carolina 63.6 51.1 56.3
verall 44.9 31.6 35.5
able 5. Data by Ethnicity (Mean Values)
Variable n Mean 95% Confidence Interval
reprocessing total nucleated cell count ( 106)
White 5414 1242.2 1230.1–1254.5
Black 957 1159.2 1132.3–1186.7
Asian 296 1216.9 1169.6–1266.0
Hispanic 932 1163.6 1138.5–1189.2
Other 258 1212.7 1158.4–1269.6
D34 Count ( 106)
White 5408 3.37 3.31–3.44
Black 957 2.73 2.60–2.87
Asian 296 3.55 3.27–3.85
Hispanic 929 3.19 3.05–3.33
Other 258 3.51 3.20–3.85
ostprocessing total nucleated cell count ( 106)/volume (mL)
White 5417 11.6 11.5–11.7
Black 957 11.0 10.8–11.2
Asian 296 11.7 11.3–12.0
Hispanic 932 11.9 11.7–12.1
Other 258 11.6 11.2–12.0S
B&MTr unrelated donor. Because clinical studies have in-
icated an improvement in survival with the infusion
f higher cell doses per kilogram, cord blood banks
ave attempted to provide cord blood units with high
ell doses [11,13,17]. Another goal of cord blood
anks is to ensure a racially/ethnically diverse donor
ool to accommodate racially/ethnically diverse trans-
lant recipients. However, early reports from the
MDP cord blood banks showed that in 4 of the 5
reas surveyed, minority recruitment was worse in the
ord blood program than in the marrow donor center
22]. Other banks may have had more success with
ecruitment of minority cord blood donors [10,27,28].
or example, the Cord Blood Transplantation trial
ecently reported that 22% of their cord blood units
ere collected from Hispanic donors, 15% from black
onors, and 8% from Asian donors [28]. In our cur-
ent study, we achieved racial/ethnic diversity by es-
ablishing cord blood collection sites in hospitals with
diverse maternal population.
Studies of solid organ donation report less interest
n donation among blacks [29,30]. The Task Force on
rgan Transplantation has been addressing this issue
y fostering communication among families and care-
ivers; the donor rate for minorities increased from
6% in 1988 to 23% in 1995 among cadaver donors
31]. For living donors, the donation rate increased
rom 24% to 28% in the same period.
In this study, we have shown that a racially/ethni-
ally diverse donor pool can be achieved in a national
etwork of cord blood banks: the ARC Cord Blood
rogram. We did not compare our results from cord
lood donors with those of marrow donors in this
Ethnicity
anic (%) Native American/Other (%) P Value (2 test)
31.3 35.7 .271
45.1 33.1 <.001
33.6 42.2 <.001
39.1 41.7 .005
23.1 50.0 <.001
53.2 65.5 <.001
42.6 40.6 <.001
able 6. CD34 Count ( 106) by Ethnicity by Process Date
Ethnicity
Before
July 1, 2001
After
July 1, 2001
n
Geometric
Mean n
Geometric
Mean
hite 1987 3.39 3421 3.35
lack 160 3.22 797 2.64
sian or Pacific Islander 82 3.29 214 3.67
ispanic 339 2.97 590 3.32
ative American/other 98 3.00 160 3.86Hispite  ethnicity interaction, P  .032.
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2tudy. As expected, certain collection sites were more
ikely to recruit donors from a different racial/ethnic
roup; Detroit, for example, had the highest percent-
ge of black donors in the program. San Diego had the
ighest percentage of Hispanic donors in the pro-
ram. Other cord blood banks are also increasing their
inority recruitment; the Cord Blood Transplanta-
ion study recently reported that of the ﬁrst 179 trans-
lantations facilitated by their banks, 33% of the re-
ipients and 34% of the donors were nonwhite [28].
his increase in the number of minority donors may
eﬂect greater awareness and availability of resources
or minority recruitment. The increase in minority
onors may also represent a greater willingness to
articipate because of less risk of cord blood versus
one marrow or peripheral blood stem cell donation.
Our data did show variation among the different
acial/ethnic groups, particularly for CD34 counts.
n 3 collection areas (the Midwest, the Northwest, and
orth Carolina), blacks had signiﬁcantly lower
D34 counts. In all 7 locations, the percentage of
ord blood units stored from black donors was always
he lowest of all the races. This difference may reﬂect
ifference in CD34 measurements. It is possible that
iologic factors related to delivery or socioeconomic
ifferences may also be involved; however, these issues
ere not addressed in this study. These data suggest
hat even greater recruitment efforts are needed for
lack donors to provide cord blood units with high
D34 counts. Collection of sufﬁcient cord blood
nits from black donors will require additional re-
ources for 2 reasons: (1) fewer of the mothers who
onsent will have cord units banked (45% versus 32%)
nd (2) more cords may need to be collected to achieve
high CD34 count. Additional efforts will also be
eeded to recruit Asian donors because of high rates
f deferral as a result of positive infectious disease
arkers.
The study is limited by site-speciﬁc differences. A
reliminary study among ARC cord blood banks
ested identical cord blood samples in different pro-
essing laboratories of the ARC Cord Blood Program.
espite use of similar methods, there was variation in
ell counts and CD34 counts among the different
rocessing laboratories. This difference was greatest
or CD34 counts, with up to a 3-fold variation in 1
xercise [32]. In 1 exercise that used aliquots of the
ame frozen sample, CD34 results ranged from 15
ells per microliter in the Portland laboratory to 63
ells per microliter in the Minnesota laboratory.
herefore, our results were controlled for site and
hould be interpreted cautiously. There may be sim-
lar site-speciﬁc differences in other large cord blood
rograms with more than 1 processing laboratory
19,21].
Another limitation of the study is the use of self-
eported racial and/or ethnic designations based on a
74creening questionnaire ﬁlled out by the mother be-
ore donation. We also collect information (if avail-
ble) on the putative father of the baby, but this
nformation was not analyzed in this study. In addi-
ion, the terms used, eg, “Caucasian” and “Hispanic,”
ompromise a wide group of donors with potentially
ifferent ethnic origins. No attempt was made to con-
rm the accuracy of the self-reported racial designa-
ions. A survey of Hispanics that used surnames, med-
cal records, and self-identiﬁcation found that many
elf-identiﬁed Hispanics were identiﬁed incorrectly
sensitivity of 68%) [33]. A recent review summarizes
he difﬁculty of studying race and ethnicity in medical
esearch [34].
Our study did not examine the various HLA types
mong the different racial/ethnic groups. The fre-
uencies of rare antigens and haplotypes were not
ddressed in this study but form the basis for future
ork. In some reports, minorities represent 30% of
ord blood transplant recipients [9,28]. Presumably,
hese patients did not have an alternative acceptable
onor source. A recent report from the International
one Marrow Transplant Registry indicated that sur-
ival after HLA-identical sibling transplantation was
ower for Hispanic patients than for whites [35]. An
nalogous study has not been performed for patients
eceiving cord blood transplants.
In summary, a diverse population of cord blood
onors can be achieved in a national network of cord
lood banks. In some sites, cord blood units from
lack donors had lower CD34 counts. Future studies
ill address the cord blood outcomes of the various
acial/ethnic groups.
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